APOE and Alzheimer disease: For example, previous work has shown alterations in connectivity in the functional network most affected by AD in APOE ε4 carriers versus non-carriers; these differences were observed in the absence of differences in gray matter volume in adolescent and young adults [59,60], and in older individuals in the absence of cognitive symptoms or amyloid deposition in the brain [61].